Happy long weekend to my Canadian and American friends ,
This week in the Conference Coverage section in the CLL Society website cllsociety.org, we’ve posted an interview with Dr. Januario Castro out of UCSD where we discussed the results of his trial studying HDMP + obinutuzumab in both untreated and relapsed refractory CLL. You can view that interview from ASH 2015 here. cllsociety.org/2016/08/cast...
I am off later this week to Portugal to speak at the the European School of Hematology's 2nd International Conference on New Concepts in B-Cell Malignancies in front of about hematologist where I will be discussing the American challenges on ensuring that the breakthroughs in therapies reach the patients that need them.
My blog bkoffman.blogspot.com has more details on what we are doing and where we will be. We may be coming to a a city near you to see if there is enough interest in getting a local CLL specific support and education going.
We are all in this together.